Soligenix Says FDA Grants Type A Meeting Regarding New Drug Application For HyBryte
(RTTNews) - Biopharmaceutical company Soligenix, Inc. (SNGX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the contents of a refusal to file (RTF) letter previously issued regarding the Company's new drug application (NDA) for HyBryte (synthetic hypericin) in the treatment of early stage cutaneous T-cell lymphoma (CTCL), a rare cancer.
The company has successfully demonstrated statistically significant results in a Phase 3 clinical trial.
The company said it intends to provide a further update once it receives the minutes from the meeting or when it has more clarity on next steps, which is anticipated by or before the end of April.
For More Such Health News, visit rttnews.com
read more
Australian Market Trims Early Losses In Mid-market
The Australian market is trimming its early losses in mid-market moves on Tuesday, reversing the gains in the previous session, following the negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,200 level, with weakness across most sectors led by mining and technology stocks, after US President Donald Trump confirmed he will move forward with higher tariffs.
RTTNews
|
5j 29min yang lalu
Sensex, Nifty Likely To Drift Lower On Trade War Fears
Indian shares may drift lower on Tuesday against the backdrop of persistent FII selling, continuing uncertainty around tariffs and ongoing geopolitical tensions between Russia and Ukraine.
RTTNews
|
5j 38min yang lalu
Japanese Market Sharply Lower
The Japanese stock market is trading sharply lower on Tuesday, reversing the sharp gains in the previous session, following the negative cues from Wall Street overnight, with the Nikkei 225 falling well below the 37,300 level, with weakness across most sectors led by index heavyweights and technology stocks, after US President Donald Trump confirmed he will move forward with higher tariffs.
RTTNews
|
6j 48min yang lalu
Australian Market Significantly Lower
The Australian stock market is trading significantly lower on Tuesday, reversing the gains in the previous session, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,200 level, with weakness across most sectors led by mining and technology stocks, after US President Donald Trump confirmed he will move forward with higher tariffs.
RTTNews
|
7j 9min yang lalu
TSX Ends Sharply Lower As Stocks Tumble On Tariff Jitters
The Canadian market ended sharply lower on Monday due to heavy selling in energy and technology sectors. Stocks from materials, industrials and consumer discretionary sectors were the other major losers.
RTTNews
|
8j 51min yang lalu
Dollar Loses Ground On Growth Worries
The U.S. dollar drifted lower on Monday, losing ground against almost all its major counterparts, amid rising concerns about global growth, and prospects of a rate cut by the Federal Reserve earlier than expected.
RTTNews
|
9j 25min yang lalu
Euro Rallies Amid Ukraine Peace Plan
The euro firmed against its major counterparts on Monday, amid the prospect of higher defense spending in Europe to deter Russian aggression.
RTTNews
|
12j 24min yang lalu
Canadian Market Down Firmly In Negative Territory
The Canadian market, which retreated after a positive start Monday morning, continues to languish in negative territory well past noon, with stocks from technology and energy sectors reeling under selling pressure.
RTTNews
|
12j 25min yang lalu
